For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
1
views
0
references
 Top references
cited by
7
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      3,062
      similar
       All similar
      • Record: found
      • Abstract: not found
      • Article: not found

      CXCR4 antagonist (BL-8040) to enhance antitumor effects by increasing tumor infiltration of antigen-specific effector T-cells.

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          Title: Journal of Clinical Oncology
          Abbreviated Title: JCO
          Publisher: American Society of Clinical Oncology (ASCO)
          ISSN (Print): 0732-183X
          ISSN (Electronic): 1527-7755
          Publication date Created: February 10 2018
          Publication date (Print): February 10 2018
          Volume: 36
          Issue: 5_suppl
          Page: 73
          Affiliations
          [1 ]Georgia Cancer Center, Augusta, GA;
          [2 ]BioLineRx Ltd., Modi'in, Israel;
          [3 ]BioLineRx Ltd., Modi’in, Israel;
          [4 ]BioLineRx, Modi’in, Israel;
          Article
          DOI: 10.1200/JCO.2018.36.5_suppl.73
          SO-VID: 149158ba-e841-43ef-a3d8-9e59b7b62b4c
          Copyright © © 2018
          History

          Data availability:

          Comments

          Comment on this article

          scite_

          Similar content3,062

          See all similar

          Cited by7

          See all cited by